CAMLINFINE - Camlin Fine Sciences

Camlin Fine Sciences

CAMLINFINE · Chemicals > Chemicals · Chairman: Ashish Dandekar · MD: Ashish Dandekar · Listing date: Jan. 20, 2015 · Employees: 430 · Mumbai · http://www.camlinfs.com

Stock Price vs Company Growth

2.3%

2.2%

17.6%

18.2%

24.5%

49.9%

9.1%

10y

1.7%

all

1.9%

🤔 How to analyze this graph?

Last Traded Price

₹ 104 2.3%

147

Company Overview

Sales

1,862 Cr

Growth: 4.0%

Profit after Tax

5.88 Cr

Growth: -78.7%

Small Cap

2,002 Cr

P/S: 1.1x

Industry P/S: 1.5x

Fundamentals

Sales (Cr)	₹ 1,862
Growth	4.0%
EBITDA	4.6%
P/S	1.1x
Dividend	0.0%
P/E	-34.7x
Book Value	₹ 52.5
PEG Ratio	-8.6x
ROE	0.6%
P/B	2.0x

Shareholding Pattern

Institutions

Icici Prudential Midcap Fund

8.62 %

Sbi Flexicap Fund

7.93 %

Infinity Direct Holding

4.82 %

Nirmal Vinod Momaya

2.82 %

Kuwait Investment Authority Fund 225

1.99 %

Promoters

Ashish Subhash Dandekar

11.02 %

Camart Industries Ltd

4.17 %

Vibha Agencies Pvt Ltd

2.04 %

Anagha Subhash Dandekar

1.19 %

Cafco Consultants Limited

1.17 %

Others

Increase Decrease No change

Company Profile Detailed

Camlin, the corporate group, was established in 1931 and is a pioneer in art and stationery material in India. Camlin diversified into Pharmaceuticals and Fine Chemicals two decades ago. The Fine Chemical Division of Camlin got de-merged into a separate company named as Camlin Fine Chemicals on 22nd December 2006. The entire management team and employees of Camlin Fine Chemicals Division are now a part of the independent legal entity formed under the Indian Companies Act 1956.

Belongs to (9 Indices) view more

Investors (98)

visa.cap...

ddi.cons...

sbi.magn...

Followers (7)

sudheer....

ratnesh2

indrajee...